Midgard Science

OmniParticles

Seoul, South Korea omniparticles.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

OmniParticles is a nanomedicine CDMO that develops nanoparticle drug substances and provides aseptic fill-finish for clinical-phase drug products. It operates in Seoul, Korea, with separate drug substance and drug product GMP facilities in the same building.

Services

  • Nanoparticle drug substance CDMO

    End-to-end development and manufacturing for nanoparticle drug substances, from concept translation and formulation refinement through scale-up and GMP mass production with CMC support.

  • Aseptic sterile fill-finish

    Aseptic fill-finish for preclinical and Phase I/II/III clinical supply, including batches of 2,000–5,000 vials under Grade A conditions in open RABS with a fully single-use product-contact train.

  • GMP and non-GMP drug substance manufacturing

    Manufacturing of nanomedicine drug substance from preparation to purified bulk with GMP-compliant processes.

  • QC/QA analysis

    QC/QA protocols for verifying nanomedicine integrity, safety, and performance against global regulatory standards.

  • Batch records and release documentation

    Preparation of manufacturing reports, CoT, and CoA with full traceability to support regulatory filings.

  • CMC documentation and Module 3 CTD support

    Preparation of essential CMC documentation and Module 3 scientific and technical writing for global regulatory submissions.

  • Regulatory consulting

    Guidance on early-development regulatory strategy and global frameworks for IND and related clinical trial applications.

Capabilities

Assays and studies
  • Fill-finish
  • Small molecules
  • Peptides
  • LNP
  • DLS
  • TEM
5 more
  • Zeta-potential
  • HPLC
  • SEC
  • ICP-MS
  • Sterility testing
Scale and capacity
  • Batches of 2,000–5,000 vials
  • GMP drug substance manufacturing plant
  • Purpose-built sterile drug product suite
  • Two manufacturing suites
Therapeutic areas
  • Acute diseases
  • Chronic diseases
  • Inflammatory diseases
  • Ischemic stroke
  • Intracerebral hemorrhage
  • Sepsis
  • Subarachnoid hemorrhage
  • Traumatic brain injury

Instruments and platforms

  • DLS
  • TEM
  • Zeta-potential
  • HPLC
  • SEC mode
  • Triple detector
  • ICP-MS

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Peptide
  • LNP / formulation

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: drug substance manufacturing and facility operations

Details

Type
CRDMO
Founded
2011
Office
Engineering 2021, 7 (9), 4446–4453 •Biomaterials 2020, 239, 119859 •ACS Nano
Serves
Global

Similar labs